Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113735826B reveals a novel Pd-catalyzed carbonylation route for high-purity quinolone intermediates, offering substantial cost reduction and supply chain reliability.
Patent CN112125856A details a safe, palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering reliable supply and cost reduction in API manufacturing.
Patent CN112125856A details a safe palladium-catalyzed carbonylation using solid CO surrogates for high-purity quinazolinone intermediates, offering significant cost reduction.
Novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel palladium-catalyzed method for carbonyl-bridged biheterocycles avoids toxic CO gas. Offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed method for 3-arylquinolin-2(1H)ones using benzisoxazole. High yield, scalable process for pharmaceutical intermediates.
Patent CN112239456A reveals a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel CuCl catalyzed route for 1,2,4-triazolyl arylamines. Offers scalable production and cost efficiency for pharmaceutical intermediate supply chains.
Patent CN111423381B details a mild palladium-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN112480015B reveals a one-pot Pd-catalyzed method for 2-trifluoromethyl quinazolinones, offering cost-effective API intermediate manufacturing solutions.
Patent CN115260080B reveals efficient Pd-catalyzed route. Reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN115353511A details a safe Pd-catalyzed multicomponent route avoiding toxic CO gas, offering cost reduction in API manufacturing and scalable production.
Patent CN115403505B details a novel palladium-catalyzed route using sulfonyl chloride. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113045503B details a novel Pd-catalyzed carbonylation for 2-CF3-quinazolinones. This method offers high yields, mild conditions, and cost-effective API intermediate manufacturing.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112538054B details a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering high yields and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN119118976A reveals a nickel-catalyzed route for thioester pyrones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for quinolinone derivatives offers high yields and broad functional group tolerance for pharmaceutical intermediates.
Patent CN115260080B reveals a novel one-step carbonylation route for indole-3-carboxamide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.